Production milestone for wood-to-feed producer
US biotech company Arbiom, which is developing solutions to convert wood into protein for aquafeed and other applications, has reached a milestone in its demonstration programme by completing continuous, stable operation of its fermentation technology over a seven-day period without contamination or product quality issues, it said in a press release.
Fermentation and downstream process stages ran smoothly and continuously to successfully produce more than half a tonne of its SylPro protein, which exceeded Arbiom’s initial target.
To complete the continuous run, Arbiom worked with BBEPP, a partner in the SYLFEED Consortium, at BBEPP’s facility in Belgium. SYLFEED is a European Union-funded four-year project aimed at scaling up Arbiom’s wood-to-food technology to convert wood residues into a protein-rich ingredient comprised of single cell protein (SCP) and test it in aquaculture applications.
Scaling up
The company said that transitioning from batch to continuous operations is essential in scaling-up its industrial biotechnology to commercial production, as it strongly improves process economics of a representative commercial production facility.
Continuous operation of the fermentation process in partnership with BBEPP is a significant achievement in commercialising the company’s technology to economically produce SylPro, Arbiom said.
Significant achievement
“This significant achievement is a testament to our strong collaboration with Arbiom and the dedication of everyone on the team,” said Muriel Dewilde, business development manager with BBEPP. “We look forward to working with Arbiom to build on this successful demonstration as the company continues to scale-up its process technology.”
Arbiom chief executive Marc Chavrel said: “We are very pleased to have achieved this latest advancement in commercialisation of Arbiom’s technology, with continuous operation and stable, robust process performance, at demonstration-scale.”
To date, Arbiom has completed more than 1,500 hours of process scale-up operations. By the end of 2020 Arbiom will have run its bioconversion process continuously at the 15m³ scale (15,000 litres) as part of the critical path within the demonstration programme, the company said.